Ratio of Ovarian Stroma and Total Ovarian Area by Ultrasound in Prediction of Hyperandrogenemia in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome: A Diagnostic Test

    Pichai Leerasiri, Thanyarat Wongwananuruk, Manee Rattanachaiyanont, Suchada Indhavivadhana, Kitirat Techatraisak, Surasak Angsuwathana
    Image of study
    TLDR Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.
    In a study of 222 Thai women with polycystic ovary syndrome (PCOS), the ovarian stromal area to total ovarian area (S/A) ratio, measured by ultrasound, was evaluated as a predictor for biochemical hyperandrogenism. The S/A ratio at a cut-off of 0.33 showed modest predictability with an area under the curve of 0.537, sensitivity of 36.6%, specificity of 72.1%, positive predictive value of 83.8%, and negative predictive value of 20.9%. Predictability improved when the S/A ratio was combined with clinical hyperandrogenism, resulting in sensitivity, specificity, PPV, and NPV of 72.1%, 58.1%, 87.8%, and 33.3%, respectively. The study concluded that the S/A ratio alone is not a reliable predictor for biochemical hyperandrogenism in Thai women with PCOS, but it is more effective when combined with clinical signs of hyperandrogenism. The findings suggest that biochemical hyperandrogenism should be tested in all Thai women with PCOS for appropriate treatment, particularly where serum androgen measurement is not available. The research was funded by the Siriraj Grant for Research and Development Fund from the Faculty of Medicine Siriraj Hospital, Mahidol University.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    4 / 4 results